From: Prevalence and healthcare burden of pulmonary alveolar proteinosis
Indexed Comorbidity | PAP | Control | p value |
---|---|---|---|
Myocardial Infarction | 9 (5.5%) | 4 (2.4%) | 0.157 |
Congestive Heart Failure | 30 (18.3%) | 5 (3%) | < 0.001 |
Peripheral Vascular Disease | 10 (6.1%) | 4 (2.4%) | 0.101 |
Cerebrovascular Disease | 15 (9.1%) | 4 (2.4%) | 0.009 |
Dementia | 0 (0%) | 1 (0.6%) | 0.317 |
Chronic Pulmonary Disease | 71 (43.3%) | 16 (9.8%) | < 0.001 |
Connective Tissue Disease | 14 (8.5%) | 1 (0.6%) | < 0.001 |
Peptic Ulcer Disease | 3 (1.8%) | 2 (1.2%) | 0.652 |
Mild Liver Disease | 15 (9.1%) | 2 (1.2%) | 0.001 |
Diabetes without Complications | 36 (22%) | 20 (12.2%) | 0.019 |
Diabetes with End-Organ Damage | 8 (4.9%) | 2 (1.2%) | 0.054 |
Hemiplegia/Paraplegia | 1 (0.6%) | 0 (0%) | 0.317 |
Renal Disease | 16 (9.8%) | 2 (1.2%) | < 0.001 |
Non-metastatic Cancer Hematologic Malignancy | 15 (9.1%) | 6 (3.7%) | 0.042 |
Moderate/Severe Liver Disease | 2 (1.2%) | 0 (0%) | 0.0156 |
Metastatic Solid Tumour | 2 (1.2%) | 2 (1.2%) | > 0.9999 |